Rohan Eric John Beckwith

This inventor holds 15 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Protein Degradation. Top assignees: Novartis Ag, Other. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rohan Eric John Beckwith. Retrieved from https://idiyas.com/inventor/rohan-eric-john-beckwith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 12)

% Patents Active = 86.7

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 65(Granted Patents)

Location History:

Cambridge, MA (US) (2018 - 2020)
Maynard, MA (US) (2016 - 2024)

Company Filing History:

14 out of 3,978

Novartis Ag

patents

1 out of 834,601

Other

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Protein Degradation

Lipid Compositions

Chemical Derivatives

Active Agents

Degraders

Isoindolin Derivatives

Selective Degradation

Compositions

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12767647 - Glue degraders and methods of use thereof (2026-10-20),

2. 12479817 - SUBSTITUTED 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF (2025-11-25),

3. 11999802 - Compositions and methods for selective protein degradation (2024-06-04),

4. 11833142 - 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2023-12-05),

5. 11185537 - 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2021-11-30),

6. 11053218 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2021-07-06),

7. 10844002 - Lipids and lipid compositions for the delivery of active agents (2020-11-24),

8. 10792361 - Lipids and lipid compositions for the delivery of active agents (2020-10-06),

9. 10729775 - Lipids and lipid compositions for the delivery of active agents (2020-08-04),

10. 10647701 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2020-05-12),

11. 10640489 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2020-05-05),

12. 10414755 - 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2019-09-17),

13. 10125092 - Lipids and lipid compositions for the delivery of active agents (2018-11-13),

14. 10124065 - Lipids and lipid compositions for the delivery of active agents (2018-11-13),

15. 9504747 - Lipids and lipid compositions for the delivery of active agents (2016-11-29),

Title: The Innovative Contributions of Rohan Eric John Beckwith

Introduction

Rohan Eric John Beckwith, an accomplished inventor based in Maynard, MA, has made significant strides in the realm of patentable innovations. With a remarkable portfolio consisting of 13 patents, Beckwith has contributed to the field of biochemistry and pharmacology through his inventive methodologies and compositions.

Latest Patents

Among his latest patents, one noteworthy invention is titled "Compositions and methods for selective protein degradation." This innovation introduces compositions that include a fusion polypeptide alongside methods for creating a fusion polypeptide that incorporates a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide, along with a heterologous polypeptide of interest.

Another significant patent is centered around "3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof." This disclosure presents a compound of Formula (I'), demonstrating Beckwith's commitment to pioneering new chemical entities that hold promise in various applications.

Career Highlights

Throughout his career, Beckwith has made impactful contributions while working at renowned organizations, including Novartis AG. His role at such prestigious companies has allowed him to apply his inventive talents towards advancing scientific knowledge and development.

Collaborations

Rohan’s exceptional work has been nurtured through collaborations with talented individuals like Ritesh Bhanudasji Tichkule and Gabriel Grant Gamber. These partnerships have fostered an environment of innovation, leading to the successful development of transformative ideas and technologies.

Conclusion

In conclusion, Rohan Eric John Beckwith exemplifies the spirit of innovation and invention. His extensive patent portfolio and collaborative efforts underscore the importance of creativity in scientific advancement. As he continues to push the boundaries of research, his contributions will undoubtedly impact the field for years to come.

Profile summary based on public USPTO records.